If you got a question, look no further.
We post the most common questions
in our FAQ section.
Please fill in the form below to receive a Free Sample of the Report.
Summary“Biotherapix SLU - Product Pipeline Review - 2012” provides data on the Biotherapix SLU’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Biotherapix SLU’s corporate website, SEC filings, investor presentations and featured press releases, both from Biotherapix SLU and industry-specific third party sources, put together by Global Markets Direct’s team. Scope- Biotherapix SLU - Brief Biotherapix SLU overview including business description, key information and facts, and its locations and subsidiaries.- Review of current pipeline of Biotherapix SLU human therapeutic division.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.- Product profiles for late stage and clinical stage products of Biotherapix SLU with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the Biotherapix SLU’s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products.Reasons to buy- Evaluate Biotherapix SLU’s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of Biotherapix SLU in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the Biotherapix SLU’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. - Exploit collaboration and partnership opportunities with Biotherapix SLU. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of Biotherapix SLU and identify potential opportunities in those areas.
Table of Contents 2List of Tables 4List of Figures 4Biotherapix SLU Snapshot 5Biotherapix SLU Overview 5Key Information 5Key Facts 5Biotherapix SLU – Research and Development Overview 6Key Therapeutic Areas 6Biotherapix SLU – Pipeline Review 8Pipeline Products by Stage of Development 8Pipeline Products – Monotherapy 9Biotherapix SLU – Pipeline Products Glance 10Biotherapix SLU – Early Stage Pipeline Products 10Pre-Clinical Products/Combination Treatment Modalities 10Biotherapix SLU – Drug Profiles 11Btx-201 11Product Description 11Mechanism of Action 11R&D Progress 11Btx-301 12Product Description 12Mechanism of Action 12R&D Progress 12Btx-401 13Product Description 13Mechanism of Action 13R&D Progress 13Btx-402 14Product Description 14Mechanism of Action 14R&D Progress 14Btx-403 15Product Description 15Mechanism of Action 15R&D Progress 15Btx-404 16Product Description 16Mechanism of Action 16R&D Progress 16Btx-405 17Product Description 17Mechanism of Action 17R&D Progress 17Btx-501 18Product Description 18Mechanism of Action 18R&D Progress 18Btx-502 19Product Description 19Mechanism of Action 19R&D Progress 19Biotherapix SLU – Locations And Subsidiaries 20Head Office 20Financial Deals Landscape 21Biotherapix SLU, Deals Summary 21Biotherapix SLU, Pharmaceuticals & Healthcare, Deal Details 22Partnerships 22Biotherapix Enters Into Co-Development Agreement With Digna Biotech 22Appendix 23Methodology 23Coverage 23Secondary Research 23Primary Research 23Expert Panel Validation 23Contact Us 24Disclaimer 24List of TablesBiotherapix SLU, Key Information 5Biotherapix SLU, Key Facts 5Biotherapix SLU – Pipeline by Indication, 2012 7Biotherapix SLU – Pipeline by Stage of Development, 2012 8Biotherapix SLU – Monotherapy Products in Pipeline, 2012 9Biotherapix SLU – Pre-Clinical, 2012 10Biotherapix SLU, Deals Summary 21Biotherapix Enters Into Co-Development Agreement With Digna Biotech 22List of FiguresBiotherapix SLU – Pipeline by Indication, 2012 7Biotherapix SLU – Pipeline by Stage of Development, 2012 8Biotherapix SLU – Monotherapy Products in Pipeline, 2012 9